Characterization of the 1918 "Spanish" influenza virus matrix gene segment
about
Pathogenesis of the 1918 pandemic influenza virusThe pathology of influenza virus infections1918 Influenza: the mother of all pandemicsSynthetic viruses: a new opportunity to understand and prevent viral diseaseGenomic analysis of increased host immune and cell death responses induced by 1918 influenza virusThe relationship between encephalitis lethargica and influenza: a critical analysisStructural Characterization of the 1918 Influenza Virus H1N1 NeuraminidaseMolecular virology: was the 1918 pandemic caused by a bird flu?Characterization of the 1918 influenza virus polymerase genesAberrant innate immune response in lethal infection of macaques with the 1918 influenza virusAnalysis by single-gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low-pathogenicity avian influenza virus in mice.Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.Novel origin of the 1918 pandemic influenza virus nucleoprotein gene.Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in miceAvian influenza: a pandemic waiting in the wings?The origin and virulence of the 1918 "Spanish" influenza virus.Discovery and characterization of the 1918 pandemic influenza virus in historical context.Immunogenicity and protective efficacy of recombinant M2e.Hsp70c (Hsp70(359-610)) fusion protein against influenza virus infection in mice.Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets.Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses.MicroRNA expression and virulence in pandemic influenza virus-infected mice.Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.Insights on influenza pathogenesis from the grave.Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak.PhyloMap: an algorithm for visualizing relationships of large sequence data sets and its application to the influenza A virus genome.M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protectionApplications of high-throughput genomics to antiviral research: evasion of antiviral responses and activation of inflammation during fulminant RNA virus infection.LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.Characterization of the noncoding regions of the 1918 influenza A H1N1 virus.Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.Comparative pathology of select agent influenza a virus infections.Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases.An influenza A virus vaccine based on an M2e-modified alphavirus.Mass spectrometry analysis of influenza virus reassortant clones does not reveal an influence of other viral proteins on S-acylation of hemagglutinin.
P2860
Q21131430-17F048D5-EAF2-444C-9E70-017979A9152EQ22255608-5063F46B-6BF8-4028-9036-88757B6F20D8Q22305649-DBD0B6EC-98E5-458D-A982-F857501D6F09Q24650817-E179F268-32A2-4667-85CF-E5E94977AF17Q24652550-271FB174-8920-4879-A843-58635B41B689Q24655322-3E3B292A-BBC2-407F-85C7-22AF7D12B200Q27651719-D7F50EB8-1FF5-4DF6-9624-979D3CF1B99AQ28236775-1F00C452-8270-4BD6-A162-1A024F63AC31Q28275749-AF6A90F6-EFD9-480F-A085-20EDDA8B5BA6Q28283850-F1BB9CF6-98D4-4D70-8FC7-B3A833560126Q30224564-D04BCEBB-66FF-4C04-BC58-FCB3D202A8B2Q30339011-1175F53C-83F2-4641-8E3F-9D9E25B61944Q30344017-F233B3FE-C3DC-472D-8784-DEA042F800D9Q30351800-B3FEA287-2F0D-4158-8179-2E9EBAC74CAAQ30357794-8F8FCF6E-21B2-4C7D-B7DE-C2800FC4AE40Q30361962-809A6C9A-2F2B-434F-89DF-40FF2B2E2276Q30365240-E2B4C829-3B2C-4423-965C-775A5CC7FFD8Q30366089-08382A0F-4398-42C8-910B-7962C62629A2Q30374134-2CA98AB0-C326-4A0F-9676-6545E958CCA2Q30375647-9B882A64-AF90-40E0-A607-7EF16B896DE7Q30384382-F5004437-10FE-460F-8382-FBFFFD6EF24AQ30387664-0FA36DFD-15A8-4F8B-ACD5-AEF62084A3F5Q30398228-531F74FA-FBE0-4E6E-AA84-808C5ED2A4AAQ30407187-9852AE7B-0DA4-471A-8BF6-A1B7F1A0F877Q30407253-B552282F-576D-4B16-BB3A-003760AC0623Q33937414-54E24638-7BD2-4586-AEF0-471552E0DE79Q35565480-01DB41CD-F1F8-4585-A55C-611EA4488B47Q36277930-B7ED181F-EAF3-4180-A56C-40D418278A12Q36596819-7C98597D-E34B-4BAF-880F-E78024364F18Q37007016-5A098982-BA7D-4AAA-9D21-A03A264C29E8Q37547331-8AE4CB93-0AD2-4BF1-A860-125BE5EC4C4BQ37645689-E6F793F9-B5DE-4BC0-A6E8-C61811246936Q37777544-B76FAA36-56AB-46BA-8955-13A80276DAB8Q37841282-196F5D57-F0B7-4106-9B9F-619FBF1C868EQ45325550-219D4D62-F909-4CF4-9309-384BF7A6010EQ45354345-AFAD0E0A-2B4B-496F-A45B-EC3848111C82
P2860
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@ast
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@en
type
label
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@ast
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@en
prefLabel
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@ast
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@en
P2860
P50
P1433
P1476
Characterization of the 1918 "Spanish" influenza virus matrix gene segment
@en
P2093
Sherman McCall
P2860
P304
10717-10723
P356
10.1128/JVI.76.21.10717-10723.2002
P577
2002-11-01T00:00:00Z